Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has the proven expertise, superior technologies and
flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and reliable global supply.

Catalent has built this expertise with partners of all sizes, from the smallest innovators to the largest of pharmaceutical leaders, advancing
thousands of molecules through development towards commercial supply. Providing both specific, tailored program support and comprehensive,
integrated solutions, Catalent reduces its partners’ risks on a variety of programs, including orphan drugs, accelerated and breakthrough treatments,
vaccines, next-generation cell and gene therapies, and rare diseases.

Its team of approximately 15,000 at 45+ global sites manages over 1,100 active development programs and supports more than 180 product launches annually.

Every year, Catalent produces more than 72 billion doses of over 7,000 products for more than 1,000 customers, equating to 1 in 20 doses taken by patients globally.